Daniel Umbricht
Daniel Umbricht
F. Hoffmann - La Roche Ltd, University of Zurich
Email verificata su roche.com
Titolo
Citata da
Citata da
Anno
Genome-wide association analyses identify 44 risk variants and refine the genetic architecture of major depression
NR Wray, S Ripke, M Mattheisen, M Trzaskowski, EM Byrne, A Abdellaoui, ...
Nature genetics 50 (5), 668-681, 2018
10682018
Antibodies against β-amyloid slow cognitive decline in Alzheimer's disease
C Hock, U Konietzko, JR Streffer, J Tracy, A Signorell, B Mller-Tillmanns, ...
Neuron 38 (4), 547-554, 2003
10042003
Mismatch negativity in schizophrenia: a meta-analysis
D Umbricht, S Krljes
Schizophrenia research 76 (1), 1-23, 2005
6942005
Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia
D Umbricht, L Schmid, R Koller, FX Vollenweider, D Hell, DC Javitt
Archives of general psychiatry 57 (12), 1139-1147, 2000
5732000
Treatment-resistant schizophrenia: treatment response and resistance in psychosis (TRRIP) working group consensus guidelines on diagnosis and terminology
OD Howes, R McCutcheon, O Agid, A De Bartolomeis, NJM Van Beveren, ...
American Journal of Psychiatry 174 (3), 216-229, 2017
3632017
How specific are deficits in mismatch negativity generation to schizophrenia?
D Umbricht, R Koller, L Schmid, A Skrabo, C Grbel, T Huber, H Stassen
Biological psychiatry 53 (12), 1120-1131, 2003
2952003
Cognitive functioning in the schizophrenia prodrome
AE Simon, K Cattapan-Ludewig, S Zmilacher, D Arbach, K Gruber, ...
Schizophrenia bulletin 33 (3), 761-771, 2007
2752007
Clozapine and weight gain.
DSG Umbricht, S Pollack, JM Kane
The Journal of clinical psychiatry, 1994
2671994
Clozapine and weight gain.
DSG Umbricht, S Pollack, JM Kane
The Journal of clinical psychiatry, 1994
2661994
Has an angel shown the way? Etiological and therapeutic implications of the PCP/NMDA model of schizophrenia
DC Javitt, SR Zukin, U Heresco-Levy, D Umbricht
Schizophrenia bulletin 38 (5), 958-966, 2012
2592012
Effects of clozapine on auditory event-related potentials in schizophrenia
D Umbricht, D Javitt, G Novak, J Bates, S Pollack, J Lieberman, J Kane
Biological psychiatry 44 (8), 716-725, 1998
2551998
Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers
D Umbricht, R Koller, FX Vollenweider, L Schmid
Biological psychiatry 51 (5), 400-406, 2002
2402002
Clozapine and haloperidol in moderately refractory schizophrenia: a 6-month randomized and double-blind comparison
JM Kane, SR Marder, NR Schooler, WC Wirshing, D Umbricht, RW Baker, ...
Archives of General Psychiatry 58 (10), 965-972, 2001
2202001
Electrophysiological indices of automatic and controlled auditory information processing in first-episode, recent-onset and chronic schizophrenia
DSG Umbricht, JA Bates, JA Lieberman, JM Kane, DC Javitt
Biological psychiatry 59 (8), 762-772, 2006
1982006
Postictal and chronic psychoses in patients with temporal lobe epilepsy
D Umbricht, G Degreef, WB Barr, JA Lieberman, S Pollack, N Schaul
American Journal of Psychiatry 152 (2), 224-231, 1995
1731995
Effect of bitopertin, a glycine reuptake inhibitor, on negative symptoms of schizophrenia: a randomized, double-blind, proof-of-concept study
D Umbricht, D Alberati, M Martin-Facklam, E Borroni, EA Youssef, ...
JAMA psychiatry 71 (6), 637-646, 2014
1682014
Ultra high-risk state for psychosis and non-transition: a systematic review
AE Simon, E Velthorst, DH Nieman, D Linszen, D Umbricht, L de Haan
Schizophrenia research 132 (1), 8-17, 2011
1652011
Translating glutamate: from pathophysiology to treatment
DC Javitt, D Schoepp, PW Kalivas, ND Volkow, C Zarate, K Merchant, ...
Science translational medicine 3 (102), 102mr2-102mr2, 2011
1512011
Defining subjects at risk for psychosis: a comparison of two approaches
AE Simon, DN Dvorsky, J Boesch, B Roth, E Isler, P Schueler, C Petralli, ...
Schizophrenia research 81 (1), 83-90, 2006
1342006
The FDA-NIMH-MATRICS guidelines for clinical trial design of cognitive-enhancing drugs: what do we know 5 years later?
RW Buchanan, RSE Keefe, D Umbricht, MF Green, T Laughren, ...
Schizophrenia bulletin 37 (6), 1209-1217, 2011
1332011
Il sistema al momento non pu eseguire l'operazione. Riprova pi tardi.
Articoli 1–20